Skip to main content

Alysia McDonald: Intergenerational Progr...

Alysia McDonald: Intergenerational Programs’ Effect on the Mental Health of the Elderly

Intergenerational Programs’ Effect on the Mental Health of the Elderly   Abstract Background: Mental health disorders, such as late-life depression and dementia, are a growing problem the aging population faces. Common treatment medications carry with them many negative aspects. Intergenerational programs are being sought out as an alternative or additional therapy to medication. These programs […]

Karielle Brugman: Angiotensin-Converting...

Karielle Brugman: Angiotensin-Converting Enzyme Inhibitors Can Slow the Progression of Cognitive Decline In Elderly Patients With Dementia

Angiotensin-Converting Enzyme Inhibitors Can Slow the Progression of Cognitive Decline In Elderly Patients With Dementia Abstract Background: Dementia is a slow progressing neurodegenerative disease characterized by loss of executive functioning, communication ability, and activities of daily living. With few treatment options currently approved for dementia, angiotensin-converting enzyme inhibitors (ACE-I) have been implicated as a new […]

Jeffrey Otis: Pioglitazone and Alzheimer...

Jeffrey Otis: Pioglitazone and Alzheimers Disease, a Possible Treatment and Preventative Modality

Pioglitazone and Alzheimers Disease, a Possible Treatment and Preventative Modality  ABSTRACT Background: Alzheimers disease is common and debilitating, and diabetes is a widely documented risk factor for the development of Alzheimers disease. Given that Alzheimers disease and diabetes are two extremely common and comorbid conditions in geriatric populations that greatly affect quality of life, it […]